Sysmex Europe has launched its HISCL automated immunoassay platform for [...]

spliesense-cystic-fibrosis-foundation-spl84-phase2b SpliSense has secured up to $13 million in funding [...]

Mabion has signed a letter of intent with French technology [...]

Innovative Molecules has expanded its virology pipeline with a new [...]

Confo Therapeutics has presented preclinical data supporting the development of [...]

CERo Therapeutics Holdings, Inc has shared a Phase 1 update [...]

Lonza has entered an exclusive licensing agreement with Antharis Therapeutics [...]

Grifols has launched Fesilty in the USA, making the fibrinogen [...]

The National Institute for Health and Care Excellence has recommended [...]

Elicio Therapeutics has reported that its Phase 2 Amplify-7P trial [...]